1.Research progress on the application of CAR-T combination therapy in solid tumors
Jinli GAO ; Xinpei CAI ; Qinqin XU
Chongqing Medicine 2025;54(7):1719-1723,1728
Chimeric antigen receptor T-cell(CAR-T)immunotherapy utilizes genetic engineering to modify human T cells,enabling them to specifically recognize antigens on tumor cell surfaces through antibod-ies and to link with signaling molecules necessary for T-cell activation,thereby enhancing the T cells'specific cytotoxic activity against tumors.Currently,it demonstrates significant efficacy in the treatment of hematolog-ical tumors;however,numerous challenges remain in treating solid tumors,as its effectiveness is influenced by drug resistance of antigen-negative tumor cells,immune suppression in the tumor microenvironment,and ex-haustion of T cell immune function.This article provides a review of the application of current combination therapies utilizing CAR-T cell therapy,aiming to offer novel approaches for the treatment of solid tumors.
2.Research progress on mechanisms and animal models of comorbid depression and tumors
Yakun REN ; Xinpei WANG ; Xingjiu YANG ; Mengyuan LI ; Ran GAO
Acta Laboratorium Animalis Scientia Sinica 2025;33(9):1393-1402
The comorbidity of depression and cancer represents a significant global public health challenge,severely impacting patients' quality of life and clinical outcomes.This systematic review considers the epidemiological characteristics,clinical implications,and major challenges in current research regarding comorbid depression and cancer,focusing on the role of depression in promoting tumor progression and suppressing immune function via the neuroendocrine-immune regulatory network.We discuss the dynamic changes and interaction mechanisms of depression-related neurotransmitters(such as serotonin and norepinephrine)and stress hormones(such as cortisol)within the tumor microenvironment.We also reveal the molecular mechanisms by which depression regulates malignant biological behaviors such as tumor immune evasion,metastasis,and angiogenesis via activation of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system.This review also evaluates the application value and limitations of existing animal models for studying the mechanisms underlying the comorbidity of depression and cancer,emphasizing the importance and urgency of developing more precise comorbidity models to uncover the mechanisms and explore management strategies.This review aims to raise awareness of risk prediction,clinical interventions,and basic research on the comorbidity of depression and cancer,to provide a theoretical foundation and new research directions for developing depression-cancer comorbidity models.
3.Research progress on mechanisms and animal models of comorbid depression and tumors
Yakun REN ; Xinpei WANG ; Xingjiu YANG ; Mengyuan LI ; Ran GAO
Acta Laboratorium Animalis Scientia Sinica 2025;33(9):1393-1402
The comorbidity of depression and cancer represents a significant global public health challenge,severely impacting patients' quality of life and clinical outcomes.This systematic review considers the epidemiological characteristics,clinical implications,and major challenges in current research regarding comorbid depression and cancer,focusing on the role of depression in promoting tumor progression and suppressing immune function via the neuroendocrine-immune regulatory network.We discuss the dynamic changes and interaction mechanisms of depression-related neurotransmitters(such as serotonin and norepinephrine)and stress hormones(such as cortisol)within the tumor microenvironment.We also reveal the molecular mechanisms by which depression regulates malignant biological behaviors such as tumor immune evasion,metastasis,and angiogenesis via activation of the hypothalamic-pituitary-adrenal axis and the sympathetic nervous system.This review also evaluates the application value and limitations of existing animal models for studying the mechanisms underlying the comorbidity of depression and cancer,emphasizing the importance and urgency of developing more precise comorbidity models to uncover the mechanisms and explore management strategies.This review aims to raise awareness of risk prediction,clinical interventions,and basic research on the comorbidity of depression and cancer,to provide a theoretical foundation and new research directions for developing depression-cancer comorbidity models.
4.Application of bedside sitting activity combined with staged breathing training in patients with COPD and respiratory failure
Chongge YANG ; Xinpei LIANG ; Yan DAI ; Rui LI ; Ran LI ; Su ZHANG ; Zhancheng GAO
Chinese Journal of Nursing 2024;59(23):2847-2852
Objective To explore the application effect of bedside sitting activity combined with staged breathing training on patients with chronic obstructive pulmonary disease(COPD)complicated with respiratory failure,and to provide references for nurses to carry out pulmonary rehabilitation therapy.Methods A total of 120 COPD patients with respiratory failure in a tertiary A hospital of Beijing City were selected from May 2021 to December 2023 as the study subjects.The study subjects were divided into an experimental group and a control group(each n=60)by the random number table method.The experimental group received bedside sitting activity combined with staged breathing training on the basis of routine lung rehabilitation nursing,while the control group was given routine lung rehabilitation nursing.After intervention,the blood gas indicators,lung function respiratory capacity,exercise capacity,and quality of life were compared between groups after intervention.Results After intervention,the arterial partial blood oxygen saturation and arterial partial pressure of oxygen in the experimental group were better than those in the control group(P<0.05).The experimental group had higher maximum ventilatory volume,forced expiratory volume in the first second and vital capacity than those in the control group(P<0.05).After intervention,the lung function respiratory capacity and quality of life in the experimental group were better compared with those in the control group(P<0.05).The exercise capacity of the experimental group was higher than that in the control group(P<0.05).Conclusion Bedside sitting activity combined with staged breathing training can effectively improve lung function and enhance exercise tolerance and quality of life in patients with COPD and respiratory failure.
5.Study on the effect factors of GDFT under guidance of hemodynamic monitor on the PONV of patients after gynecological laparoscopic surgery
Yujia HAN ; Xinpei SUN ; Yujie QI ; Xueqi GAO ; Jianfeng YU
China Medical Equipment 2024;21(1):123-129
Objective:To investigate the effect of goal-directed fluid therapy(GDFT)under the guidance of LIDCOrapid hemodynamic monitor on postoperative nausea and vomiting(PONV)of patients after gynecological laparoscopic surgery.Methods:A total of 90 patients who underwent laparoscopic extensive hysterectomy under general anesthesia in Affiliated Hospital of Shandong Second Medical University from August 2020 to June 2021 were selected,and they were divided into observation group and control group as random number table,with 45 cases in each group.Patients in control group supplemented fluid according to the guidance of urine output and mean arterial pressure(MAP).Patients in observation group supplemented fluid according to GDFT under guidance of stroke volume variation(SVV).The MAP values,heart rates(HR),SVV values and cardiac index(CI)values at the 10th min after patients entered the operation room(T0),the 3rd min after anesthesia induction(T1),and the 3rd min(T2),the 30th min(T3)and the 1st h(T4)after Terndelenburg position,and the time of completing surgery(T5)were observed.In addition,the intraoperative intake and output volume of liquid,the indicators of gastrointestinal function recovery after surgery,and the length of stay also were observed.The PONV incidence of main outcome indicators,and the PONV scores of postoperative 0-6h(T6),6-12 h(T7),12-24 h(T8)and 24-48 h(T9)of secondary outcome indicators,as well as the number of patients who received the treatment of antiemetic compensation after surgery,were analyzed.Results:The PONV incidence of observation group was significantly lower than that of control group(x2=6.40,P<0.05).The PONV scores of postoperative T6 and T7 of observation group were significantly lower than those of control group(t=4.92,3.42,P<0.05),respectively.The HR and CI value at T4 of observation group were significantly higher than those of control group(t=0.73,0.64,P<0.05),while the SVV of observation group increased from T3 to T5,with significant differences(t=2.28,3.42,4.10,P<0.05),respectively.The intraoperative crystalline fluid input and total infusion volume decreased,while colloidal fluid input increased,and the differences of them between two groups were significant(t=15.10,12.36,8.19,P<0.05),respectively.The postoperative exhaust time,defecation time and feeding time of observation group were significantly earlier than these of control group(t=3.79,2.09,2.54,P<0.05),respectively.But there was no statistical difference in the length of stay between the two groups.Conclusion:GDFT,which is guided by LIDCOrapid hemodynamic monitor,may decrease the incidence of PONV of gynecological laparoscopic surgery and the severity of PONV within 12 hours after surgery.
6.A prospective single-arm study of the efficacy and safety of lobaplatin-based HIPEC combined with optimal support in the treatment of abdominal metastatic cancer
Zhui KE ; Jie GAO ; Jingyi LU ; Xinpei LUO ; Xuemin HE ; Zhuqing LIU ; Min YUAN ; Xianling GUO ; Qing XU
China Oncology 2024;34(12):1115-1122
Background and purpose:Lobaplatin,as a traditional chemotherapeutic drug,is widely used in the treatment of malignant tumor.In recent years,its application in the field of hyperthermic intraperitoneal chemotherapy(HIPEC)has garnered increasing attention.This study evaluated the efficacy and safety of lobaplatin-based HIPEC in advanced abdominal metastatic cancer.Methods:This study collected data of patients with advanced cancers and malignant ascites who treated in the Cancer Center of Shanghai Tenth People's Hospital,Tongji University School of Medicine,from January 2019 to January 2023.We excluded patients who did not meet the inclusion criteria.Short-term efficacy was assessed by changes in ascitic fluid volume,and long-term survival was analyzed using the Kaplan-Meier method.The correlation between CA12-5 levels before and after treatment was evaluated using Pearson correlation analysis.Baseline characteristics and treatment outcomes were described using descriptive statistics,and the changes in CA12-5 levels before and after treatment were compared using significance tests(P<0.01).Data entry and statistical analyses were conducted using SPSS version 26.0,and survival curves and efficacy plots were generated with GraphPad Prism(10.4.0 version).The study was approved by the Ethics Committee of Shanghai Tenth People's Hospital(Ethics approval number:SHSY-IEC-5.0/24K134/P01).This prospective single-arm study strictly adhered to the guideline of Consolidated Standards of Reporting Trials(CONSORT)checklist.Results:A total of 21 patients were enrolled in this study.The median age of the patients was 61 years(ranging from 31 to 71 years).Among the 21 patients,5(23.8%)achieved complete remission(CR),5(23.8%)achieved partial remission(PR),8(38.1%)had stable disease(SD),and 3(14.3%)experienced disease progression(PD).The overall response rate(ORR)was 47.6%,and the disease control rate(DCR)was 85.7%.Survival analysis revealed a median progression-free survival(PFS)of 12.33 months and a median overall survival(OS)of 16.37 months.Analysis of tumor markers showed a significant negative correlation between efficacy and CA12-5 levels(P<0.01).Adverse reactions primarily included myelosuppression,hepatic and renal impairment,and nausea and vomiting,with most adverse events being mild to moderate.Conclusion:Lobaplatin-based HIPEC is effective in the treatment of advanced gastrointestinal malignancies with malignant ascites,providing survival benefits and demonstrating good safety.CA12-5 may serve as a valuable predictor of poor prognosis.
7.A prospective single-arm study of the efficacy and safety of lobaplatin-based HIPEC combined with optimal support in the treatment of abdominal metastatic cancer
Zhui KE ; Jie GAO ; Jingyi LU ; Xinpei LUO ; Xuemin HE ; Zhuqing LIU ; Min YUAN ; Xianling GUO ; Qing XU
China Oncology 2024;34(12):1115-1122
Background and purpose:Lobaplatin,as a traditional chemotherapeutic drug,is widely used in the treatment of malignant tumor.In recent years,its application in the field of hyperthermic intraperitoneal chemotherapy(HIPEC)has garnered increasing attention.This study evaluated the efficacy and safety of lobaplatin-based HIPEC in advanced abdominal metastatic cancer.Methods:This study collected data of patients with advanced cancers and malignant ascites who treated in the Cancer Center of Shanghai Tenth People's Hospital,Tongji University School of Medicine,from January 2019 to January 2023.We excluded patients who did not meet the inclusion criteria.Short-term efficacy was assessed by changes in ascitic fluid volume,and long-term survival was analyzed using the Kaplan-Meier method.The correlation between CA12-5 levels before and after treatment was evaluated using Pearson correlation analysis.Baseline characteristics and treatment outcomes were described using descriptive statistics,and the changes in CA12-5 levels before and after treatment were compared using significance tests(P<0.01).Data entry and statistical analyses were conducted using SPSS version 26.0,and survival curves and efficacy plots were generated with GraphPad Prism(10.4.0 version).The study was approved by the Ethics Committee of Shanghai Tenth People's Hospital(Ethics approval number:SHSY-IEC-5.0/24K134/P01).This prospective single-arm study strictly adhered to the guideline of Consolidated Standards of Reporting Trials(CONSORT)checklist.Results:A total of 21 patients were enrolled in this study.The median age of the patients was 61 years(ranging from 31 to 71 years).Among the 21 patients,5(23.8%)achieved complete remission(CR),5(23.8%)achieved partial remission(PR),8(38.1%)had stable disease(SD),and 3(14.3%)experienced disease progression(PD).The overall response rate(ORR)was 47.6%,and the disease control rate(DCR)was 85.7%.Survival analysis revealed a median progression-free survival(PFS)of 12.33 months and a median overall survival(OS)of 16.37 months.Analysis of tumor markers showed a significant negative correlation between efficacy and CA12-5 levels(P<0.01).Adverse reactions primarily included myelosuppression,hepatic and renal impairment,and nausea and vomiting,with most adverse events being mild to moderate.Conclusion:Lobaplatin-based HIPEC is effective in the treatment of advanced gastrointestinal malignancies with malignant ascites,providing survival benefits and demonstrating good safety.CA12-5 may serve as a valuable predictor of poor prognosis.
8.Application of bedside sitting activity combined with staged breathing training in patients with COPD and respiratory failure
Chongge YANG ; Xinpei LIANG ; Yan DAI ; Rui LI ; Ran LI ; Su ZHANG ; Zhancheng GAO
Chinese Journal of Nursing 2024;59(23):2847-2852
Objective To explore the application effect of bedside sitting activity combined with staged breathing training on patients with chronic obstructive pulmonary disease(COPD)complicated with respiratory failure,and to provide references for nurses to carry out pulmonary rehabilitation therapy.Methods A total of 120 COPD patients with respiratory failure in a tertiary A hospital of Beijing City were selected from May 2021 to December 2023 as the study subjects.The study subjects were divided into an experimental group and a control group(each n=60)by the random number table method.The experimental group received bedside sitting activity combined with staged breathing training on the basis of routine lung rehabilitation nursing,while the control group was given routine lung rehabilitation nursing.After intervention,the blood gas indicators,lung function respiratory capacity,exercise capacity,and quality of life were compared between groups after intervention.Results After intervention,the arterial partial blood oxygen saturation and arterial partial pressure of oxygen in the experimental group were better than those in the control group(P<0.05).The experimental group had higher maximum ventilatory volume,forced expiratory volume in the first second and vital capacity than those in the control group(P<0.05).After intervention,the lung function respiratory capacity and quality of life in the experimental group were better compared with those in the control group(P<0.05).The exercise capacity of the experimental group was higher than that in the control group(P<0.05).Conclusion Bedside sitting activity combined with staged breathing training can effectively improve lung function and enhance exercise tolerance and quality of life in patients with COPD and respiratory failure.
9.Study of the protective effects of lower body negative pressure strategy and thigh cuff strategy on cerebral blood flow during simulated push pull maneuver
Changyang XING ; Yuan GAO ; Xinpei WANG ; Yunnan LIU ; Jiaxin ZHANG ; Chen WANG ; Xing ZHANG ; Jia LI ; Ting CHANG ; Shu ZHANG ; Yong LIU ; Lijun YUAN ; Feng GAO
Chinese Journal of Aerospace Medicine 2021;32(1):1-6
Objective:To compare the protective effects of cerebral blood flow during simulated push pull maneuver (PPM) between lower body negative pressure (LBNP) strategy and thigh cuff (TC) strategy.Methods:It was a repeated cross-over design study. Fifteen healthy young male subjects were recruited. All subjects underwent the control bout (simulated PPM without any intervention), PPM with LBNP bout, and PPM with TC bout. Such position changes as "upright to head down tilt to upright" were performed by tilting table to simulate PPM. The control bout underwent normal PPM. LBNP of -40 mmHg (1 mmHg=0.133 kP) was applied prior to and during -G z stress and released at the subsequent transition to +G z stress in LBNP bout. TC of +200 mmHg was applied at bilateral upper thighs prior to and during simulated PPM. Beat-to-beat cerebral and systemic hemodynamics of the subjects were continuously recorded. Results:During the rapid -G z to +G z transition, the mean cerebral blood flow velocity (CBFVm) was decreased by 0.7-17.3 cm/s [ΔCBFVm=(-7.5±4.5) cm/s], and the mean arterial pressure at the level of middle cerebral artery(MAP MCA) was decreased by 42-76 mmHg [ΔMAP MCA=(-61.0±10.0) mmHg] in control bout. However, the change of CBFVm was -2.4-10.2 cm/s in LBNP bout, whose average value was increased (3.3±4.1) cm/s rather than decreased. The drop of MAP MCA was 23-50 mmHg [ΔMAP MCA=(-41.0±11.0) mmHg], which was significantly reduced than that in control bout ( P<0.05). The change of CBFVm in TC bout was -7.9-1.4 cm/s [ΔCBFVm=(-3.0±4.2) cm/s], and the decrease of ΔMAP MCA was 37-59 mmHg [ΔMAP MCA=(-47.0±13.0) mmHg], both of which were significantly smaller than that in control bout ( P<0.05). There was significant difference in ΔCBFVm between LBNP and TC bouts ( P<0.05), while no significant difference was found in ΔMAP MCA. Conclusions:Both the LBNP and TC strategies can protect the cerebral blood flow during simulated PPM. LBNP strategy showed better improvement of CBFVm than TC. Both strategies demonstrated protective effect by increasing diastolic cerebral blood flow.
10.Study of the protective effects of lower body negative pressure strategy and thigh cuff strategy on cerebral blood flow during simulated push pull maneuver
Changyang XING ; Yuan GAO ; Xinpei WANG ; Yunnan LIU ; Jiaxin ZHANG ; Chen WANG ; Xing ZHANG ; Jia LI ; Ting CHANG ; Shu ZHANG ; Yong LIU ; Lijun YUAN ; Feng GAO
Chinese Journal of Aerospace Medicine 2021;32(1):1-6
Objective:To compare the protective effects of cerebral blood flow during simulated push pull maneuver (PPM) between lower body negative pressure (LBNP) strategy and thigh cuff (TC) strategy.Methods:It was a repeated cross-over design study. Fifteen healthy young male subjects were recruited. All subjects underwent the control bout (simulated PPM without any intervention), PPM with LBNP bout, and PPM with TC bout. Such position changes as "upright to head down tilt to upright" were performed by tilting table to simulate PPM. The control bout underwent normal PPM. LBNP of -40 mmHg (1 mmHg=0.133 kP) was applied prior to and during -G z stress and released at the subsequent transition to +G z stress in LBNP bout. TC of +200 mmHg was applied at bilateral upper thighs prior to and during simulated PPM. Beat-to-beat cerebral and systemic hemodynamics of the subjects were continuously recorded. Results:During the rapid -G z to +G z transition, the mean cerebral blood flow velocity (CBFVm) was decreased by 0.7-17.3 cm/s [ΔCBFVm=(-7.5±4.5) cm/s], and the mean arterial pressure at the level of middle cerebral artery(MAP MCA) was decreased by 42-76 mmHg [ΔMAP MCA=(-61.0±10.0) mmHg] in control bout. However, the change of CBFVm was -2.4-10.2 cm/s in LBNP bout, whose average value was increased (3.3±4.1) cm/s rather than decreased. The drop of MAP MCA was 23-50 mmHg [ΔMAP MCA=(-41.0±11.0) mmHg], which was significantly reduced than that in control bout ( P<0.05). The change of CBFVm in TC bout was -7.9-1.4 cm/s [ΔCBFVm=(-3.0±4.2) cm/s], and the decrease of ΔMAP MCA was 37-59 mmHg [ΔMAP MCA=(-47.0±13.0) mmHg], both of which were significantly smaller than that in control bout ( P<0.05). There was significant difference in ΔCBFVm between LBNP and TC bouts ( P<0.05), while no significant difference was found in ΔMAP MCA. Conclusions:Both the LBNP and TC strategies can protect the cerebral blood flow during simulated PPM. LBNP strategy showed better improvement of CBFVm than TC. Both strategies demonstrated protective effect by increasing diastolic cerebral blood flow.

Result Analysis
Print
Save
E-mail